Harvard Bioscience, Inc. (HBIO) Reports Q4 Earnings of $0.07; Guides FY12, Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.32 +1.09%
Revenue Growth %: +6.1%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
JBLU, SICP, OMID, More
Revenue Growth %: +6.1%
Financial Fact:
Cost of product revenues: 13.32M
Today's EPS Names:
JBLU, SICP, OMID, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q4 EPS of $0.07, versus $0.11 reported last year. Revenue for the quarter came in at $29.03 million, versus $29.52 million reported last year.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.26-$0.29.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.04-$0.05.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.26-$0.29.
Harvard Bioscience, Inc. sees FY2012 EPS of $0.04-$0.05.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Flexsteel (FLXS) Tops Q1 EPS by 17c, Beats on Revenue; Offers Q2 Revenue Guidance
- German American Bancorp (GABC) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
